CD8A and neoplasm: Although M1 macrophages, NK cells, and CD8+ T cells are known to be anticancer cells, Tregs, myeloid-derived suppressor cells (MDSCs), cancer-associated fibroblasts (CAFs), and M2 macrophages are commonly thought to being tumor-accelerative cells.